<DOC>
	<DOCNO>NCT02107300</DOCNO>
	<brief_summary>To assess whether daily use NeutraSal prevent reduce dry mouth patient undergo CPAP therapy OSAS improve CPAP compliance</brief_summary>
	<brief_title>NeutraSal Treatment Xerostomia OSAS Patients Using CPAP Therapy</brief_title>
	<detailed_description>Subjects diagnose Obstructive Sleep Apnea Syndrome ( OSAS ) start CPAP treatment complain dry mouth develop worsen pre-existing dry mouth effect CPAP treatment test effectiveness NeutraSal mouthwash prevent reduce his/her dry mouth perception improve compliance CPAP .</detailed_description>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<criteria>Patient 18 year age . Patients initiated CPAP therapy initial diagnosis OSAS develop dry mouth worsen preexist dry mouth condition , effect CPAP therapy . Ability attend visit research site Patient able read and/or understand sign consent form willing participate research study Patients open mouth sore study entry . Any pathology , base judgement researcher , could negatively affect oral mucosa subsequent treatment xerostomia ( immune disorder , etc . ) Patients use prophylactic mouthwash . Patients pregnant and/or nursing . Patients become pregnant treatment period remove data . Patients low sodium diet Patients currently medication treatment xerostomia Patients &lt; 18 year age Hypersensitivity follow ingredient sodium chloride , sodium phosphate , calcium chloride sodium bicarbonate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Obstructive Sleep Apnea Syndrome</keyword>
</DOC>